New Eisai venture arm to focus on digital tech, dementia, cancer

As Eisai looks to digital technologies for dementia drug discovery, the Japanese pharma’s newly launched venture arm has made its first investment and backed Tokyo-based digital healthcare company Allm.

Eisai Co. Ltd. (Tokyo:4523) said the investment arm will invest in and partner with biopharma, diagnostic and IT companies, as well as government agencies, medical facilities and insurance companies to evaluate real world, genomic and clinical data for drug discovery in neurology and oncology...